Search

Author/Creator Cox, Lori

1. Efficacy and Safety of PF‐06651600 (Ritlecitinib), a Novel JAK3/TEC Inhibitor, in Patients With Moderate‐to‐Severe Rheumatoid Arthritis and an Inadequate Response to Methotrexate. Issue 10 (7th September 2020)

Authors:
Robinson, Michael F.; Damjanov, Nemanja; Stamenkovic, Bojana; Radunovic, Goran; Kivitz, Alan; Cox, Lori; Manukyan, Zorayr; Banfield, Christopher; Saunders, Michael; Chandra, Deepa; Vincent, Michael S.; Mancuso, Jessica; Peeva, Elena; Beebe, Jean S.
Journal:
Arthritis & rheumatology
Issue:
Volume 72:Issue 10(2020)
Page Start:
1621
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

2. Safety, Tolerability, and Pharmacokinetics of PF‐06823859, an Anti–Interferon β Monoclonal Antibody: A Randomized, Phase I, Single‐ and Multiple‐Ascending‐Dose Study. Issue 3 (22nd December 2020)

Authors:
Neelakantan, Srividya; Oemar, Barry; Johnson, Kristen; Rath, Natalie; Salganik, Mikhail; Berman, Gabe; Pelletier, Kathleen; Cox, Lori; Page, Karen; Messing, Dean; Tarabar, Sanela
Journal:
Clinical pharmacology in drug development
Issue:
Volume 10:Issue 3(2021)
Page Start:
307
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗